Compile Data Set for Download or QSAR
Report error Found 27 Enz. Inhib. hit(s) with all data for entry = 7201
TargetMacrophage colony-stimulating factor 1 receptor [538-972](Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181020(US9133183, Example 29)
Affinity DataIC50: 2nMpH: 7.5 T: 2°CAssay Description:Activity of unphosphorylated c-FMS kinase (uFMS, Seq. ID no. 1) was determined by following the production of ADP from the FMS kinase reaction with A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/23/2016
Entry Details
Go to US Patent

TargetMacrophage colony-stimulating factor 1 receptor [538-972](Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181019(US9133183, Example 15)
Affinity DataIC50: 3nMpH: 7.5 T: 2°CAssay Description:Activity of unphosphorylated c-FMS kinase (uFMS, Seq. ID no. 1) was determined by following the production of ADP from the FMS kinase reaction with A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/23/2016
Entry Details
Go to US Patent

TargetMacrophage colony-stimulating factor 1 receptor [538-972](Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181027(US9133183, Example 90)
Affinity DataIC50: 5nMpH: 7.5 T: 2°CAssay Description:Activity of unphosphorylated c-FMS kinase (uFMS, Seq. ID no. 1) was determined by following the production of ADP from the FMS kinase reaction with A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/23/2016
Entry Details
Go to US Patent

TargetMacrophage colony-stimulating factor 1 receptor [538-972](Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181018(US9133183, Example 1)
Affinity DataIC50: 6nMpH: 7.5 T: 2°CAssay Description:Activity of unphosphorylated c-FMS kinase (uFMS, Seq. ID no. 1) was determined by following the production of ADP from the FMS kinase reaction with A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/23/2016
Entry Details
Go to US Patent

TargetMacrophage colony-stimulating factor 1 receptor [538-972](Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181034(US9133183, Example 91)
Affinity DataIC50: 7nMpH: 7.5 T: 2°CAssay Description:Activity of unphosphorylated c-FMS kinase (uFMS, Seq. ID no. 1) was determined by following the production of ADP from the FMS kinase reaction with A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/23/2016
Entry Details
Go to US Patent

TargetMacrophage colony-stimulating factor 1 receptor [538-972](Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181037(US9133183, Example 42)
Affinity DataIC50: 8nMpH: 7.5 T: 2°CAssay Description:Activity of unphosphorylated c-FMS kinase (uFMS, Seq. ID no. 1) was determined by following the production of ADP from the FMS kinase reaction with A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/23/2016
Entry Details
Go to US Patent

TargetMacrophage colony-stimulating factor 1 receptor [538-972](Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181035(US9133183, Example 101)
Affinity DataIC50: 8nMpH: 7.5 T: 2°CAssay Description:Activity of unphosphorylated c-FMS kinase (uFMS, Seq. ID no. 1) was determined by following the production of ADP from the FMS kinase reaction with A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/23/2016
Entry Details
Go to US Patent

TargetMacrophage colony-stimulating factor 1 receptor [538-972](Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181023(US9133183, Compound A)
Affinity DataIC50: 13nMpH: 7.5 T: 2°CAssay Description:Activity of unphosphorylated c-FMS kinase (uFMS, Seq. ID no. 1) was determined by following the production of ADP from the FMS kinase reaction with A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/23/2016
Entry Details
Go to US Patent

TargetMacrophage colony-stimulating factor 1 receptor [538-972](Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181026(US9133183, Example 18)
Affinity DataIC50: 20nMpH: 7.5 T: 2°CAssay Description:Activity of unphosphorylated c-FMS kinase (uFMS, Seq. ID no. 1) was determined by following the production of ADP from the FMS kinase reaction with A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/23/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181023(US9133183, Compound A)
Affinity DataIC50: 196nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/23/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181019(US9133183, Example 15)
Affinity DataIC50: 370nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/23/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181019(US9133183, Example 15)
Affinity DataIC50: 670nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/23/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181020(US9133183, Example 29)
Affinity DataIC50: 898nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/23/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181023(US9133183, Compound A)
Affinity DataIC50: 990nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/23/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181027(US9133183, Example 90)
Affinity DataIC50: 3.30E+3nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/23/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181035(US9133183, Example 101)
Affinity DataIC50: 3.30E+3nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/23/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181020(US9133183, Example 29)
Affinity DataIC50: 3.30E+3nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/23/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181026(US9133183, Example 18)
Affinity DataIC50: 3.30E+3nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/23/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181034(US9133183, Example 91)
Affinity DataIC50: 3.30E+3nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/23/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181018(US9133183, Example 1)
Affinity DataIC50: 3.30E+3nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/23/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181035(US9133183, Example 101)
Affinity DataIC50: 4.00E+3nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/23/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181027(US9133183, Example 90)
Affinity DataIC50: 5.00E+3nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/23/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181037(US9133183, Example 42)
Affinity DataIC50: 5.00E+3nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/23/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181026(US9133183, Example 18)
Affinity DataIC50: 5.00E+3nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/23/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181034(US9133183, Example 91)
Affinity DataIC50: 5.00E+3nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/23/2016
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181018(US9133183, Example 1)
Affinity DataIC50: 5.00E+3nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/23/2016
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM181037(US9133183, Example 42)
Affinity DataIC50: 1.00E+4nMT: 2°CAssay Description:These tests measure the ability of compounds to inhibit the enzymatic activity of recombinant human c-Met/HGF receptor and VEGF receptor enzymatic ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/23/2016
Entry Details
Go to US Patent